Skip to content

Drug interactions

Cobimetinib + Imatinib

Severity: Major

Cobimetinib and Imatinib: major interaction.

Last updated Sources: Health Canada product monograph

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib inhibits CYP3A4 and may increase cobimetinib exposure, raising the risk of toxicity such as rash, diarrhea, hemorrhage, liver injury and retinopathy. Cobimetinib labeling advises avoiding strong or moderate CYP3A4 inhibitors.

What this interaction means in plain words

Cobimetinib and Imatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Cobimetinib belongs to Oncology; Imatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Imatinib inhibits CYP3A4, reducing cobimetinib metabolism.

What to do

Avoid the combination where possible. If it is unavoidable, reduce the cobimetinib dose as per labeling and monitor for adverse reactions.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cobimetinib and Imatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Cobimetinib with Imatinib?

MediHelp rates the interaction as major. Cobimetinib and Imatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Imatinib inhibits CYP3A4 and may increase cobimetinib exposure, raising the risk of toxicity such as rash, diarrhea, hemorrhage, liver injury and retinopathy. Cobimetinib labeling advises avoiding strong or moderate CYP3A4 inhibitors.

How serious is the interaction between Cobimetinib and Imatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If it is unavoidable, reduce the cobimetinib dose as per labeling and monitor for adverse reactions.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in